The Women's Tennis Association has implemented a groundbreaking policy requiring all female players to undergo mandatory genetic testing as a prerequisite for competing in the 2028 Los Angeles Olympics. This single-time testing initiative represents a significant shift in how sports organizations assess athlete eligibility and health protocols. The decision aims to establish standardized baseline genetic data across the professional women's tennis circuit, raising important conversations about health, privacy, and fairness in competitive sports.

Summary auto-generated by AI from the original publisher's content. Editorial standards.